Sort   by:  
 Page size 
UnknownImpact of the rs1024611 Polymorphism of CCL2 on the Pathophysiology and Outcome of Primary Myelofibrosis.
Not available
S-EPMC8196972 | biostudies-literature
UnknownPrimary myelofibrosis with increased haemoglobin concentration at presentation.
Not available
S-EPMC12624203 | biostudies-literature
UnknownJAK2 exon 14 skipping in patients with primary myelofibrosis: a minor splice variant modulated by the JAK2-V617F allele burden.
Not available
S-EPMC4305294 | biostudies-literature
UnknownDoes ruxolitinib really prolong survival in individuals with myelofibrosis? The never-ending story.
Not available
S-EPMC9006303 | biostudies-literature
UnknownMyelofibrosis-type megakaryocyte dysplasia (MTMD) as a distinct category of BCR::ABL-negative myeloproliferative neoplasms. Challenges and perspectives.
Not available
S-EPMC10079530 | biostudies-literature
UnknownUnmet Clinical Needs in the Management of Idiopathic Multicentric Castleman Disease: A Consensus-based Position Paper From an ad hoc Expert Panel.
Not available
S-EPMC10208718 | biostudies-literature
UnknownLeukocytosis and thrombosis in essential thrombocythemia and polycythemia vera: a systematic review and meta-analysis.
Not available
S-EPMC6560342 | biostudies-literature
UnknownActivation of non-canonical TGF-β1 signaling indicates an autoimmune mechanism for bone marrow fibrosis in primary myelofibrosis.
Not available
S-EPMC4338409 | biostudies-literature
UnknownShared and Distinctive Ultrastructural Abnormalities Expressed by Megakaryocytes in Bone Marrow and Spleen From Patients With Myelofibrosis.
Not available
S-EPMC7701330 | biostudies-literature
UnknownConstitutive STAT5 phosphorylation in CD34+ cells of patients with primary myelofibrosis: Correlation with driver mutation status and disease severity.
Not available
S-EPMC6675063 | biostudies-literature
Sort   by:  
 Page size